Phase II Study of Fractionated 90Y Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy as an Initial Therapy of Follicular Lymphoma (FIZZ)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by Christie Hospital NHS Foundation Trust.
Recruitment status was  Active, not recruiting
Information provided by:
Christie Hospital NHS Foundation Trust Identifier:
First received: December 14, 2011
Last updated: December 15, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
No publications provided by Christie Hospital NHS Foundation Trust

Publications automatically indexed to this study by Identifier (NCT Number):